The interaction between neurocognitive functioning, subthreshold psychotic symptoms and pharmacotherapy in 22q11.2 deletion syndrome: A longitudinal comparative study
- 1 January 2018
- journal article
- research article
- Published by Cambridge University Press (CUP) in European Psychiatry
- Vol. 48 (1) , 20-26
Abstract
Background: The 22q11.2 deletion syndrome (22q11DS) is the most common genetic syndrome associated with schizophrenia. The goal of this study was to evaluate longitudinally the interaction between neurocognitive functioning, the presence of subthreshold psychotic symptoms (SPS) and conversion to psychosis in individuals with 22q11DS. In addition, we attempted to identify the specific neurocognitive domains that predict the longitudinal evolution of positive and negative SPS, as well as the effect of psychiatric medications on 22q11DS psychiatric and cognitive developmental trajectories.Methods: Forty-four participants with 22q11DS, 19 with Williams syndrome (WS) and 30 typically developing (TD) controls, age range 12–35 years, were assessed at two time points (15.2 ± 2.1 months apart). Evaluation included the Structured Interview for Prodromal Symptoms (SIPS), structured psychiatric evaluation and the Penn Computerized Neurocognitive Battery (CNB).Results: 22q11DS individuals with SPS had a yearly conversion rate to psychotic disorders of 8.8%, compared to none in both WS and TD controls. Baseline levels of negative SPS were associated with global neurocognitive performance (GNP), executive function and social cognition deficits, in individuals with 22q11DS, but not in WS. Deficits in GNP predicted negative SPS in 22q11DS and the emergence or persistence of negative SPS. 22q11DS individuals treated with psychiatric medications showed significant improvement in GNP score between baseline and follow-up assessments, an improvement that was not seen in untreated 22q11DS.Conclusions: Our results highlight the time-dependent interplay among positive and negative SPS symptoms, neurocognition and pharmacotherapy in the prediction of the evolution of psychosis in 22q11DS.Keywords
This publication has 30 references indexed in Scilit:
- A comparative study of the neuropsychiatric and neurocognitive phenotype in two microdeletion syndromes: Velocardiofacial (22q11.2 deletion) and Williams (7q11.23 deletion) syndromesEuropean Psychiatry, 2013
- Social cognition in 22q11.2 microdeletion syndrome: Relevance to psychosis?Schizophrenia Research, 2012
- Negative symptoms in individuals at clinical high risk of psychosisPsychiatry Research, 2012
- The Effect of Methylphenidate on Prefrontal Cognitive Functioning, Inattention, and Hyperactivity in Velocardiofacial SyndromeJournal of Child and Adolescent Psychopharmacology, 2011
- Negative Symptoms and Social Cognition: Identifying Targets for Psychological InterventionsSchizophrenia Bulletin, 2011
- Probably at-risk, but certainly ill — Advocating the introduction of a psychosis spectrum disorder in DSM-VSchizophrenia Research, 2010
- Neuropsychology of the Prodrome to Psychosis in the NAPLS ConsortiumRelationship to Family History and Conversion to PsychosisNeuropsychology of Prodrome to PsychosisArchives of General Psychiatry, 2010
- Evidence That Onset of Clinical Psychosis Is an Outcome of Progressively More Persistent Subclinical Psychotic Experiences: An 8-Year Cohort StudySchizophrenia Bulletin, 2009
- Negative Symptoms in Schizophrenia: Avolition and Occam's RazorSchizophrenia Bulletin, 2008
- Prodromal Assessment With the Structured Interview for Prodromal Syndromes and the Scale of Prodromal Symptoms: Predictive Validity, Interrater Reliability, and Training to ReliabilitySchizophrenia Bulletin, 2003